Randomised controlled trial of cisapride in preterm infants

July 2000
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2000, Vol. 83 Issue 1, pF75
Academic Journal
No abstract available.


Related Articles

  • Randomised controlled trial of the effect of cisapride on the pyloric muscle in preterm infants. Pezzati, Marco; Dani, Carlo; Biadaioli, Roberto; Gambi, Beatrice; Lachina, Lucia; Rubaltelli, Firmino F. // European Journal of Pediatrics;2001, Vol. 160 Issue 9, p572 

    In this study we determined the effects of cisapride on the pyloric muscle in preterm infants. To perform a randomised, double blind, placebo controlled study, two groups each of 16 preterm newborns were given either cisapride (0.2 mg/kg every 8 h) or a placebo for at least 7 days. Infants were...

  • Respiratory syncytial virus prophylaxis reduces chronic respiratory morbidity in prematurely born infants. Greenough, Anne // Evidence Based Medicine;Apr2014, Vol. 19 Issue 2, p65 

    The author discusses a study on respiratory syncytial virus (RSV) and lower respiratory tract infections (LRTIs) with chronic respiratory morbidity (CRM) in preterm infants. Topics include the use of double blind and randomised controlled trials in 429 infants born between 33 and 35 weeks of...

  • Breastfeeding and later blood pressure.  // Caribbean Health;Aug2001, Vol. 4 Issue 4, p27 

    An abstract of the article "Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials," by A. Singhal is presented.

  • Untitled.  // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2013, Vol. 98 Issue 5, pe1 

    A correction to the article "The impact of oral sucrose on apnea and bradycardia in preterm infants: a randomised cross-over trial" published in a 2013 issue is presented.

  • Does human milk reduce infection rates in preterm infants? A systematic review. de Silva, A.; Jones, P. W.; Spencer, S. A. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Nov2004, Vol. 89 Issue 6, pF509 

    One of the reasons for advocating human milk (HM) feeding for preterm infants is the belief that this provides the infant with a degree of protection from infection. Providing fresh HM for such infants is challenging for mothers and staff, and consequently it is important that its benefits are...

  • Apnoea in premature infants and caffeine therapy. Gare, Shalabh; Lal, Mithilesh; Tin, Win // Infant;Jan2013, Vol. 9 Issue 1, p9 

    Apnoea is one of the most common clinical manifestations in preterm infants. Apnoea of prematurity (AOP) is thought to be due to immaturity of cardiorespiratory control, hence it gradually improves with advancing gestational age. Methylxanthines are the mainstay of pharmacological treatment and...

  • Lower versus Higher Oxygen Concentration for Delivery Room Stabilisation of Preterm Neonates: Systematic Review. Brown, Jennifer V. E.; Moe-Byrne, Thirimon; Harden, Melissa; McGuire, William // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background: Emerging evidence suggests that initiating delivery room respiratory support or resuscitation for term infants using lower rather than higher concentrations of oxygen reduces mortality and the risk of serious morbidity. Uncertainty exists with regard to applicability of this strategy...

  • Effect of night and day on preterm infants in a newborn nursery: randomised trial. Mann, N.P.; Haddow, R.; Stokes, L.; Goodley, S.; Rutter, N. // British Medical Journal (Clinical Research Edition);11/15/1986, Vol. 293 Issue 6557, p1265 

    Examines the effect of night and day on preterm infants in a newborn nursery. Performance of randomized controlled trial; Causes of poor nocturnal sleepings of infants; Prevalence of sleep problems in infants born prematurely.

  • Evidence-based guidelines for use of probiotics in preterm neonates.  // BMC Medicine;2011, Vol. 9 Issue 1, p92 

    The article focuses on a study conducted by Shripada C. Rao, to develop evidence based guidelines for the use of probiotic supplementation in preterm neonates. It mentions that the core guideline is developed using the data from randomised controlled trials (RCTs) of probiotics in preterm...

  • Antenatal magnesium sulfate: Neuro-protection for preterm infants. Oddie, S.; Tuffnell, D. J.; McGuire, W. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Nov2015, Vol. 100 Issue 6, pF553 

    The neuro-protective effect of antenatal magnesium sulfate on very preterm infants has been demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium administered prior to preterm delivery crosses over to the foetal circulation and acts via several pathways to reduce...


Read the Article


Sign out of this library

Other Topics